Wam Capital (ASX:WAM) has declared a full year fully franked dividend of 15.5 Australian cents per share.

The financial performance for the company in the fiscal year showed an operating profit before tax of A$233.2 million, representing a significant turnaround from the previous loss of A$425.9 million.

The company has indicated that its ability to continue paying fully franked dividends in 2024 will depend on generating additional profit reserves.

Wam Capital is a major player in the financial industry, with its services primarily focussed on banking and investment.

Brokerage firm Barrenjoey has reduced the price target for shares in property and infrastructure company Lendlease (ASX:LLC) to A$8.25 from a previous target of A$9.10.

This decision comes in the wake of Lendlease reporting a statutory loss after tax of A$232 million for the year on Monday.

Barrenjoey expressed disappointment at the fiscal year 23 result, stating it was weaker than expected for the investment income yield and operating margins.

According to Refinitiv, three out of nine analysts rate Lendlease stocks as ‘buy’ or higher, four advise to ‘hold’, and two suggest ‘sell’.

The median price target is A$9.07.

Despite these challenges, Lendlease’s stock has risen by 5.1% this year, as of the last closing.

Lendlease is a Sydney-based property and infrastructure company with operations in more than 80 countries.

Pro Medicus recently published their annual financial report, revealing an overall profit from ordinary activities after tax at A$60.6 million.

This figure shows a substantial increase in profitability for the company compared with the A$44.4 million reported the previous fiscal year.

Additionally, the revenue generated from its contracts with customers rose to A$124.9 million, up from the A$93.5 million recorded in the previous period.

The company also announced the declaration of a final dividend amount of 17.0 AU cents per share.

Pro Medicus (ASX:PME) is a leading health imaging company specializing in radiology product research and development.

GUD Holdings (ASX:GUD) has declared a final dividend of 22 AU cents per share.

The company is observing signs of improving OEM supply going into the first quarter of FY24.

There is a positive outlook for APG as sales and vehicle supply are expected to improve throughout FY24.

GUD Holdings (ASX:GUD) is also expecting further revenue and EBITA growth in FY24.

The company remains confident in APG’s ability to deliver its business case targets as OEM supply constraints and normalise.

For FY24, GUD Holdings (ASX:GUD) is expecting cash conversion to revert to 85-90%, and a working assumption is that there will be a further step up in corporation expected in FY24.

GUD Holdings is an Australian company involved in manufacturing diverse range of products including automotive parts, security products and consumer and electrical appliances.

Life360 Inc (ASX:LIFX) announced a 39% increase in half-year revenues from ordinary activities to total $138.9 million.

However, the company also reported a net loss of $18.5 million, which nevertheless demonstrated an improvement from last year’s loss of $58.2 million.

Life360 Inc is a leading technology company specialising in location-sharing and communication tools.

CSL (ASX:CSL) has forecasted its FY24 NPATA to fall within an approximate range of $2.9 billion to $3.0 billion, accounting for constant currency.

The company declared a final fully franked dividend of US$1.29 per share.

CSL reported a net profit after tax of A$2.19 billion for the 12 months ended 30 June 2023, increasing by 8% based on a constant currency basis.

The firm announced revenues of $13.31 billion for the financial year, marking an increase of 31% at constant currency.

Looking forward, CSL expects another strong year for its Seqirus division, given the high demand for its differentiated products.

Also, CSL predicts continuous robust growth in its immunoglobulins franchise following record plasma collections in the previous financial year, FY23.

CSL is a biotechnology company known for its specialty biotherapeutics and influenza vaccines.

National Australia Bank (ASX:NAB) announced its quarterly cash earnings totaling A$1.90 billion, an increase compared to A$1.80 billion reported the previous year.

The bank’s statutory net profit for the quarter was A$1.75 billion, a decrease from A$1.85 billion last year.

As the quarter ended, the CET1 ratio was reported at 11.9%.

The quarterly net interest margin was confirmed at 1.72%.

The bank stated plans to continue targeting productivity savings of approximately A$400 million in FY23.

A credit impairment charge of A$244 million was reported for the quarter.

Since March 2023, the ratio of collective provisions to credit risk weighted assets increased by 5 basis points, reaching 1.47% in the quarter.

A similar increment — of 5 basis points to 0.71% — was observed for 90+ days past due and gross impaired assets to gross loans and acceptances.

Despite the latest on-market share buy-back announced today, the capital levels of the bank remain healthy.

The liquidity and collective provision coverage are strong, with the bank having raised A$37 billion of term funding by the end of July.

National Australia Bank (ASX:NAB) is an international financial services firm, offering a full range of banking services to personal, business and corporate customers.

Treasury Wine Estates (ASX:TWE) has declared a final dividend of 17 AU cents per share.

The company’s profit for the fiscal year is reported at A$254.5 million, down slightly from A$263.2 million.

Revenue from ordinary activities has reached A$2,488.3 million, compared to the previous year’s A$2,531.8 million.

Treasury Wine Estates (ASX:TWE) remains positive about their business growth in F24 with an anticipation of high consumer demand globally, particularly for luxury wine led by Penfolds.

The company anticipates modest growth for its luxury portfolio in Treasury Americas.

Their long-term financial objective is to deliver high single-digit average earnings growth with a group EBIT margin target of 25%+.

Challenges are expected in commercial wine’s demand in Australia and the UK.

However, the demand for premium wine remains consistent.

Improved relations between Australia and China may potentially invite future review of tariffs on Australian wine.

The company is also planning to take a phased approach to Penfolds shipments across all markets.

Treasury Wine Estates (ASX:TWE) foresees Penfolds' EBITs being weighted to the second half in F24.

Heading into F24, the company retains confidence in the execution of its premiumisation strategy in response to the challenging demand for commercial wine in both Australia and UK in FY24.

Treasury Wine Estates (ASX:TWE) is a global winemaking and distribution company, known for its distinguished brands such as Penfolds, Beringer, and Stags Leap.

National Australia Bank (ASX:NAB) has announced plans to buy back up to A$1.5 billion of ordinary shares.

The bank anticipates commencing the buy-back in late August 2023.

The A$1.5 billion on-market buy-back will reduce the bank’s CET1 capital ratio by approximately 35 basis points at Level 2.

When taking into account the intended share buy-back, the pro forma June 2023 CET1 ratio of National Australia Bank (ASX:NAB) stands at 11.6% at Level 2 and 11.5% at Level 1.

National Australia Bank (ASX:NAB) is a major Australian banking institution providing various financial services.

Challenger (ASX:CGF) has announced a final dividend payout of 12.0 AU cents per share.

In addition, the company reported a total revenue from regular business operations of A$2,459.3 million, a significant increase from the previously stated A$1,212.7 million.

Challenger is an investment management firm specializing in providing a broad range of financial services and products.